1,276 Followers on Owler

GRAIL

is a California-based biotechnology company that researches and develops organ-specific screening tests for the early detection of cancer... Read more
OverviewCompetitorsFundingNews & Insights

GRAIL

is a California-based biotechnology company that researches and develops organ-specific screening tests for the early detection of cancer... Read more
GRAIL President & CEO: Josh Ofman

President & CEO

Josh Ofman

CEO Approval Rating

- -/100

2016

PublicAcquired by Illumina, Inc.NASDAQGRAL

Pharmaceuticals & Biotechnology
Biotechnology
87312836 NAICS listing

Annual Revenue
$156.1M
Employees
910
Funding
$2.5B

News

Funding
Oct 20, 2025
SEC
GRAIL received $325M in Post-IPO Equity Funding

GRAIL Competitors

1Freenome
2Thrive
3Guardant Health
4Chronix
5Biocept
6Biodesix
7Cardiff Oncology
8Boreal Genomics
9Circulogene
10Exosome Diagnostics
Unlock 15 + competitors

Trending Companies